SG11201609483YA - Novel crystalline polymorphs of pyridine derivative and method for producing the same - Google Patents
Novel crystalline polymorphs of pyridine derivative and method for producing the sameInfo
- Publication number
- SG11201609483YA SG11201609483YA SG11201609483YA SG11201609483YA SG11201609483YA SG 11201609483Y A SG11201609483Y A SG 11201609483YA SG 11201609483Y A SG11201609483Y A SG 11201609483YA SG 11201609483Y A SG11201609483Y A SG 11201609483YA SG 11201609483Y A SG11201609483Y A SG 11201609483YA
- Authority
- SG
- Singapore
- Prior art keywords
- producing
- same
- pyridine derivative
- novel crystalline
- crystalline polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014099678 | 2014-05-13 | ||
| PCT/JP2015/063632 WO2015174411A1 (en) | 2014-05-13 | 2015-05-12 | Novel crystalline polymorph of pyridine derivative, and method for producing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201609483YA true SG11201609483YA (en) | 2016-12-29 |
Family
ID=54479948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201609483YA SG11201609483YA (en) | 2014-05-13 | 2015-05-12 | Novel crystalline polymorphs of pyridine derivative and method for producing the same |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20170144987A1 (en) |
| EP (1) | EP3144304A4 (en) |
| JP (1) | JP6289619B2 (en) |
| KR (1) | KR20170003569A (en) |
| CN (1) | CN106458970B (en) |
| AR (1) | AR100404A1 (en) |
| AU (1) | AU2015260294A1 (en) |
| CA (1) | CA2948792A1 (en) |
| IL (1) | IL248901A0 (en) |
| MX (1) | MX2016014692A (en) |
| PH (1) | PH12016502222A1 (en) |
| RU (1) | RU2016148736A (en) |
| SG (1) | SG11201609483YA (en) |
| TW (1) | TW201625580A (en) |
| WO (1) | WO2015174411A1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122008000051I1 (en) * | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-ARYLTHIAZOL DERIVATIVE AND MEDICAMENT CONTAINING THEREOF |
| US8148542B2 (en) * | 2006-06-23 | 2012-04-03 | Teijin Pharma Limited | Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| TWI613203B (en) * | 2008-03-31 | 2018-02-01 | Ｃ＆Ｃ新藥研究所 | Heterocyclic derivatives |
| CN102333765B (en) * | 2009-02-27 | 2015-01-14 | 帝人制药株式会社 | Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
| JP5519201B2 (en) * | 2009-07-15 | 2014-06-11 | 光孝 北村 | Process for producing crystalline polymorph of 2- (3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecarboxylic acid |
| BRPI1011671A2 (en) * | 2009-07-15 | 2016-03-22 | Teijin Pharma Ltd | process for producing 2- (3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolacarbocyclic acid form crystals |
| PL2610248T3 (en) * | 2010-08-27 | 2016-12-30 | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound | |
| UA117359C2 (en) * | 2012-11-14 | 2018-07-25 | Тейдзін Фарма Лімітед | Pyridine derivative |
-
2015
- 2015-05-12 SG SG11201609483YA patent/SG11201609483YA/en unknown
- 2015-05-12 JP JP2016519263A patent/JP6289619B2/en not_active Expired - Fee Related
- 2015-05-12 TW TW104115029A patent/TW201625580A/en unknown
- 2015-05-12 EP EP15792728.6A patent/EP3144304A4/en not_active Withdrawn
- 2015-05-12 CA CA2948792A patent/CA2948792A1/en not_active Abandoned
- 2015-05-12 US US15/310,217 patent/US20170144987A1/en not_active Abandoned
- 2015-05-12 AU AU2015260294A patent/AU2015260294A1/en not_active Abandoned
- 2015-05-12 CN CN201580024742.0A patent/CN106458970B/en not_active Expired - Fee Related
- 2015-05-12 RU RU2016148736A patent/RU2016148736A/en not_active Application Discontinuation
- 2015-05-12 MX MX2016014692A patent/MX2016014692A/en unknown
- 2015-05-12 AR ARP150101454A patent/AR100404A1/en unknown
- 2015-05-12 KR KR1020167031454A patent/KR20170003569A/en unknown
- 2015-05-12 WO PCT/JP2015/063632 patent/WO2015174411A1/en active Application Filing
-
2016
- 2016-11-09 PH PH12016502222A patent/PH12016502222A1/en unknown
- 2016-11-10 IL IL248901A patent/IL248901A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016148736A3 (en) | 2018-06-14 |
| US20170144987A1 (en) | 2017-05-25 |
| KR20170003569A (en) | 2017-01-09 |
| EP3144304A4 (en) | 2017-10-25 |
| JPWO2015174411A1 (en) | 2017-04-20 |
| PH12016502222A1 (en) | 2017-02-06 |
| MX2016014692A (en) | 2017-02-23 |
| RU2016148736A (en) | 2018-06-14 |
| AR100404A1 (en) | 2016-10-05 |
| WO2015174411A1 (en) | 2015-11-19 |
| AU2015260294A1 (en) | 2017-01-05 |
| CA2948792A1 (en) | 2015-11-19 |
| TW201625580A (en) | 2016-07-16 |
| EP3144304A1 (en) | 2017-03-22 |
| JP6289619B2 (en) | 2018-03-07 |
| CN106458970A (en) | 2017-02-22 |
| CN106458970B (en) | 2019-09-13 |
| IL248901A0 (en) | 2017-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3159339A4 (en) | Method for producing pyridine compound | |
| IL249988A0 (en) | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine | |
| PL3174891T3 (en) | Crystalline form of nicotinamide riboside | |
| IL250628A0 (en) | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine | |
| ZA201700243B (en) | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine | |
| IL289910B1 (en) | Method for producing allulose crystals | |
| IL250984A0 (en) | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine | |
| ZA201700168B (en) | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine | |
| PT3323628T (en) | Method for producing decorative panels | |
| PT3152177T (en) | Method for expanding sand-grain-shaped raw material | |
| HK1256031A1 (en) | Method for producing novel 4-benzazonine derivative | |
| EP3190087A4 (en) | Method for producing crystalline silicotitanate | |
| EP3118194A4 (en) | Method for producing 2-acyliminopyridine derivative | |
| PL3190115T3 (en) | Salt of cephalosporin derivative, crystalline solid form of same and method for producing same | |
| HK1249518A1 (en) | Process of synthesizing substituted pyridine and pyrimidine compound | |
| EP3181545A4 (en) | Method for producing triphenylbutene derivative | |
| SG11201609483YA (en) | Novel crystalline polymorphs of pyridine derivative and method for producing the same | |
| GB201619463D0 (en) | Method for producing allulose crystals | |
| IL246920A0 (en) | Method for producing purified compound | |
| HK1208220A1 (en) | Synthesis method of 9-allylcamptothecin derivatives 9- | |
| EP3190105A4 (en) | Crystalline anti-trichophyton drug and method for producing same | |
| EP3130581A4 (en) | Method for producing heterocyclic compound | |
| EP3144305A4 (en) | Method for producing 2-pyridone compound |